A comparison of drug-metabolizing capability in isolated viable rat hepatocytes and renal tubule fragments. 1978

J R Fry, and P Wiebkin, and J Kao, and C A Jones, and J Gwynn, and J W Bridges

1. The metabolism of a number of xenobiotics has been investigated in isolated viable rat hepatocytes and kidney tubule fragments in suspension. 2. The level of Phase I metabolism was very low in the kidney cells although such cells possess appreciable Phase II metabolic capacity. 3. These findings are discussed in relation to the physiological role of cytochrome P-450 and the conjugating enzymes, and the value of intact cells systems in assessing inter-organ differences in xenobiotic metabolism.

UI MeSH Term Description Entries
D007684 Kidney Tubules Long convoluted tubules in the nephrons. They collect filtrate from blood passing through the KIDNEY GLOMERULUS and process this filtrate into URINE. Each renal tubule consists of a BOWMAN CAPSULE; PROXIMAL KIDNEY TUBULE; LOOP OF HENLE; DISTAL KIDNEY TUBULE; and KIDNEY COLLECTING DUCT leading to the central cavity of the kidney (KIDNEY PELVIS) that connects to the URETER. Kidney Tubule,Tubule, Kidney,Tubules, Kidney
D008099 Liver A large lobed glandular organ in the abdomen of vertebrates that is responsible for detoxification, metabolism, synthesis and storage of various substances. Livers
D008297 Male Males
D003374 Coumarins Synthetic or naturally occurring substances related to coumarin, the delta-lactone of coumarinic acid. 1,2-Benzopyrone Derivatives,1,2-Benzopyrones,Coumarin Derivative,Coumarine,1,2-Benzo-Pyrones,Benzopyran-2-ones,Coumarin Derivatives,Coumarines,1,2 Benzo Pyrones,1,2 Benzopyrone Derivatives,1,2 Benzopyrones,Benzopyran 2 ones,Derivative, Coumarin,Derivatives, 1,2-Benzopyrone,Derivatives, Coumarin
D004364 Pharmaceutical Preparations Drugs intended for human or veterinary use, presented in their finished dosage form. Included here are materials used in the preparation and/or formulation of the finished dosage form. Drug,Drugs,Pharmaceutical,Pharmaceutical Preparation,Pharmaceutical Product,Pharmaceutic Preparations,Pharmaceutical Products,Pharmaceuticals,Preparations, Pharmaceutical,Preparation, Pharmaceutical,Preparations, Pharmaceutic,Product, Pharmaceutical,Products, Pharmaceutical
D006923 Hymecromone A coumarin derivative possessing properties as a spasmolytic, choleretic and light-protective agent. It is also used in ANALYTICAL CHEMISTRY TECHNIQUES for the determination of NITRIC ACID. Imecromone,Methylumbelliferone,Resocyanine,4-Methylumbelliferone,7-Hydroxy-4-methyl-coumarin,Cholestil,Mendiaxon,4 Methylumbelliferone,7 Hydroxy 4 methyl coumarin
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001565 Benzoates Derivatives of BENZOIC ACID. Included under this heading are a broad variety of acid forms, salts, esters, and amides that contain the carboxybenzene structure. Benzoate,Benzoic Acids,Acids, Benzoic
D001580 Benzopyrenes A class of chemicals that contain an anthracene ring with a naphthalene ring attached to it. Benzpyrene
D001713 Biphenyl Compounds Whitish aromatic crystalline organic compounds made up of two conjoined BENZENE rings. Compounds, Biphenyl

Related Publications

J R Fry, and P Wiebkin, and J Kao, and C A Jones, and J Gwynn, and J W Bridges
January 1984, Drug metabolism and disposition: the biological fate of chemicals,
J R Fry, and P Wiebkin, and J Kao, and C A Jones, and J Gwynn, and J W Bridges
April 1979, The Journal of clinical investigation,
J R Fry, and P Wiebkin, and J Kao, and C A Jones, and J Gwynn, and J W Bridges
July 1987, Biochimica et biophysica acta,
J R Fry, and P Wiebkin, and J Kao, and C A Jones, and J Gwynn, and J W Bridges
March 2007, Toxicology in vitro : an international journal published in association with BIBRA,
J R Fry, and P Wiebkin, and J Kao, and C A Jones, and J Gwynn, and J W Bridges
January 1976, Current problems in clinical biochemistry,
J R Fry, and P Wiebkin, and J Kao, and C A Jones, and J Gwynn, and J W Bridges
September 1978, Life sciences,
J R Fry, and P Wiebkin, and J Kao, and C A Jones, and J Gwynn, and J W Bridges
September 1988, Kidney international. Supplement,
J R Fry, and P Wiebkin, and J Kao, and C A Jones, and J Gwynn, and J W Bridges
February 1986, Journal of pharmacological methods,
J R Fry, and P Wiebkin, and J Kao, and C A Jones, and J Gwynn, and J W Bridges
April 1994, Cell biology and toxicology,
J R Fry, and P Wiebkin, and J Kao, and C A Jones, and J Gwynn, and J W Bridges
November 1990, In vitro cellular & developmental biology : journal of the Tissue Culture Association,
Copied contents to your clipboard!